For research and educational purposes only. Not medical advice.
FGL Reference
Educational, not medical advice reference for FGL: Cognitive, Recovery; regulatory status, evidence posture, source review, and schedule notes.…
Reference summary
Animal and cell studies describe NCAM / FGFR-1-related neuroplasticity, neural stem-cell mobilization, and dentate-gyrus plasticity. Human outcome data are absent.
Regulatory and posture
- Categories
- Cognitive, Recovery
- Aliases
- FG Loop peptide, NCAM mimetic peptide, Neural cell adhesion molecule-derived peptide
- Evidence posture
- preclinical - Preclinical NCAM mimetic. Community neurogenesis and cognition claims are not human-validated.
- Regulatory status
- No FDA-approved FGL drug label. Published evidence is preclinical; FGL is not an approved stroke, neurogenesis, cognitive-enhancement, or neurorepair treatment.
- Content review status
- research reference
Selected public sources
- FDA bulk drug substances with significant safety risks
- PubMed: FGL NCAM mimetic peptide neural-stem-cell study
- PubMed: FGL NCAM-derived peptide dentate-gyrus plasticity study
Related tools
- Protocol builder overview - Public overview of the Pro protocol builder.